PFIZER PHARMACEUTICALS

There are a lot of pharmaceutical companies in the contemporary market but one of the leading positions is taken by the American pharmaceutical company Pfizer. It is the multinational corporation which has the headquarter in New York. This company manufactures the medications in such spheres of human health care as: immunology, oncology, cardiology, diabetology/endocrinology, and neurology.
Pfizer is well known for the manufacturing of Vigora for the ED treatment. This medicine gained the great popularity due to its efficiency and an excellent effect on the male sexual capacity. Its active ingredient Sildenafil Citrate awakes the stable erection in men who suffer from the male impotence or such a disorder as the erectile dysfunction.
The principle of Viagra work is the same for all the generic and brand drugs for the ED treatment. The main active component of the medicine increases the flow of blood vessels to certain parts of the penis and relaxes the smooth muscles. The relaxation provides the stable erection for several hours.
Another one effective drug for the ED treatment is Cialis for daily use. This medicine has the innovative formula which makes possible to treat a wide range of diseases connected with the male sexual disorders. They are: male impotence, erectile dysfunction and benign prostatic hyperplasia. This medicine contains the low concentration of the main active ingredient which provides the stable erection without any serious side effects.[see Tadalafil Tablets]

The invention of the inhaled insulin Exubera by the pharmaceutical corporation Pfizer was expected to be profitable for the company. But the attempt of Pfizer failed and the medicine is not so popular among the people who suffer from diabetes. Many companies still believe in the efficiency and great perspectives of the inhaled insulin and have the plans to manufacture this medicine in the future. But the original manufacturer Ajanta Pharma Kamagra Oral Jelly refuses to continue the process of Exubera mass production.
Another one problem for the company is the growth of the prices on its products comparing with the generic analogs of the medicines. It means that the original medicines are not so widespread in the consumer pharma market. To read more about the current situation of the company click.